Epidemiology, Etiology, and Histopathology
Publisher
Springer Singapore
Reference20 articles.
1. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
https://doi.org/10.3322/caac.21262
.
3. Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Prim. 2017;3:1–19.
https://doi.org/10.1038/nrdp.2017.22
.
4. Li H-T, Duymich CE, Weisenberger DJ, Liang G. Genetic and epigenetic alterations in bladder cancer. Int Neurourol J. 2016;20:S84–94.
https://doi.org/10.5213/inj.1632752.376
.
5. Höglund M. The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles. Urol Oncol Semin Orig Investig. 2012;30:533–40.
https://doi.org/10.1016/j.urolonc.2012.04.001
.